ZA200903499B - Indoles which act as via receptor antagonists - Google Patents

Indoles which act as via receptor antagonists

Info

Publication number
ZA200903499B
ZA200903499B ZA200903499A ZA200903499A ZA200903499B ZA 200903499 B ZA200903499 B ZA 200903499B ZA 200903499 A ZA200903499 A ZA 200903499A ZA 200903499 A ZA200903499 A ZA 200903499A ZA 200903499 B ZA200903499 B ZA 200903499B
Authority
ZA
South Africa
Prior art keywords
indoles
act
receptor antagonists
via receptor
antagonists
Prior art date
Application number
ZA200903499A
Other languages
English (en)
Inventor
Caterina Bissantz
Christophe Grundschober
Raffaello Masciadri
Hasane Ratni
Mark Rogers-Evans
Patrick Schnider
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38983746&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200903499(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA200903499B publication Critical patent/ZA200903499B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200903499A 2006-12-08 2009-05-20 Indoles which act as via receptor antagonists ZA200903499B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06125663 2006-12-08

Publications (1)

Publication Number Publication Date
ZA200903499B true ZA200903499B (en) 2010-03-31

Family

ID=38983746

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200903499A ZA200903499B (en) 2006-12-08 2009-05-20 Indoles which act as via receptor antagonists

Country Status (21)

Country Link
US (4) US20080139617A1 (xx)
EP (1) EP2089381B1 (xx)
JP (1) JP2010511660A (xx)
KR (1) KR101050558B1 (xx)
CN (1) CN101541786A (xx)
AR (1) AR064137A1 (xx)
AT (1) ATE472544T1 (xx)
AU (1) AU2007328994B2 (xx)
BR (1) BRPI0720441A2 (xx)
CA (1) CA2671324A1 (xx)
CL (1) CL2007003503A1 (xx)
DE (1) DE602007007512D1 (xx)
ES (1) ES2345132T3 (xx)
IL (1) IL198683A0 (xx)
MX (1) MX2009005541A (xx)
NO (1) NO20091832L (xx)
PE (1) PE20081380A1 (xx)
RU (1) RU2009120443A (xx)
TW (1) TW200829570A (xx)
WO (1) WO2008068184A1 (xx)
ZA (1) ZA200903499B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101050558B1 (ko) * 2006-12-08 2011-07-19 에프. 호프만-라 로슈 아게 Ｖ1ａ 수용체 길항제로서 작용하는 인돌
MX2009005544A (es) * 2006-12-08 2009-06-05 Hoffmann La Roche Indoles.
PE20081401A1 (es) 2006-12-28 2008-10-24 Hoffmann La Roche Derivados de indol como antagonistas de receptores vasopresina
EP2199967A1 (en) * 2008-12-08 2010-06-23 Electronics and Telecommunications Research Institute Apparatus for providing digital contents using dmb channel and method thereof
WO2014127350A1 (en) * 2013-02-18 2014-08-21 The Scripps Research Institute Modulators of vasopressin receptors with therapeutic potential
GB201521059D0 (en) * 2015-11-30 2016-01-13 Isis Innovation Inhibitors of metallo-beta-lactamases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5924990B2 (ja) * 1979-11-21 1984-06-13 協和醗酵工業株式会社 新規なピペリジン誘導体
TW199153B (xx) * 1990-08-07 1993-02-01 Dtsuka Seiyaku Kk
JPH09500134A (ja) * 1993-07-16 1997-01-07 メルク エンド カンパニー インコーポレーテッド ベンゾオキサジノンおよびベンゾピリミジノンピペリジニル早産防止オキシトシン受容体拮抗剤
CO5150201A1 (es) 1998-09-07 2002-04-29 Hoffmann La Roche Derivados de piperidina
NZ522116A (en) 2000-05-12 2004-04-30 Solvay Pharmaceuticals B Piperazine and piperidine compounds that have partial agonism towards dopamine D2-receptor subfamily and affinity for relevant serotonin and/or noradrenergic receptors
CA2501539A1 (en) 2002-10-17 2004-04-29 Amgen Inc. Benzimidazole derivatives and their use as vanilloid receptor ligands
BRPI0612988A2 (pt) 2005-07-14 2010-12-14 Hoffmann La Roche derivados de indol-3-il-carbonil-espiro-piperidina como antagonistas de receptor v1a
EP1912976B1 (en) * 2005-07-21 2008-11-12 F. Hoffmann-Roche AG Indol-3-yl-carbonyl-piperidin-benzoimidazole derivatives as v1a receptor antagonists
DE602006018334D1 (de) 2005-09-28 2010-12-30 Hoffmann La Roche Indol-3-ylcarbonylazaspiroderivate als vasopressinrezeptorantagonisten
KR101050558B1 (ko) * 2006-12-08 2011-07-19 에프. 호프만-라 로슈 아게 Ｖ1ａ 수용체 길항제로서 작용하는 인돌

Also Published As

Publication number Publication date
AU2007328994B2 (en) 2012-03-08
JP2010511660A (ja) 2010-04-15
KR101050558B1 (ko) 2011-07-19
KR20090078368A (ko) 2009-07-17
WO2008068184A1 (en) 2008-06-12
CA2671324A1 (en) 2008-06-12
TW200829570A (en) 2008-07-16
EP2089381B1 (en) 2010-06-30
ES2345132T3 (es) 2010-09-15
EP2089381A1 (en) 2009-08-19
US20080139548A1 (en) 2008-06-12
DE602007007512D1 (de) 2010-08-12
ATE472544T1 (de) 2010-07-15
NO20091832L (no) 2009-07-07
BRPI0720441A2 (pt) 2014-01-07
AU2007328994A1 (en) 2008-06-12
PE20081380A1 (es) 2008-09-18
MX2009005541A (es) 2009-06-05
US20080139618A1 (en) 2008-06-12
AR064137A1 (es) 2009-03-18
US8071622B2 (en) 2011-12-06
CL2007003503A1 (es) 2008-07-04
US20080269290A1 (en) 2008-10-30
CN101541786A (zh) 2009-09-23
US20080139617A1 (en) 2008-06-12
US7799923B2 (en) 2010-09-21
RU2009120443A (ru) 2011-01-20
IL198683A0 (en) 2010-02-17

Similar Documents

Publication Publication Date Title
HRP20151108T1 (xx) Antagonisti nogo-receptora
ZA200800320B (en) Indol-3-carbonyl-spiro-piperidine derivatives as Via receptor antagonists
EP2099454A4 (en) AMINOPYRROLIDINES AS CHEMOKINE RECEPTOR ANTAGONISTS
EP2058304A4 (en) P2X4 RECEPTOR ANTAGONIST
EP2244575A4 (en) ANTAGONISTS OF THE ANGIOTENSIN II RECEPTOR
SI2094690T1 (sl) Derivati 2-aza-biciklo(3.1.0)heksana kot antagonisti receptorja za oreksin
EP2151236A4 (en) G PROTEIN COUPLED RECEPTOR AGONIST
HK1136302A1 (en) Progesterone receptor antagonists
IL187424A0 (en) C5a RECEPTOR ANTAGONISTS
EP2184278A4 (en) P2X4 RECEIVER ANTAGONIST
EP2009992A4 (en) ANTAGONISTS OF THE INTERLEUKIN 8 RECEPTOR
IL196587A0 (en) 2-phenyl-indoles as prostaglandin d2 receptor antagonists
ZA200705237B (en) C5A receptor antagonists
EP1874302A4 (en) ANTAGONISTS OF ANGIOTENSIN II RECEPTORS
IL198542A0 (en) 2-aminoquinolines as 5-ht(5a)receptor antagonists
ZA200806065B (en) Oxazoloisoquinoline derivatives as thrombin receptor antagonists
IL192693A0 (en) Urotensin ii receptor antagonists
EP2153736A4 (en) NEW LEUKOTRIEN RECEPTOR ANTAGONIST
ZA200903499B (en) Indoles which act as via receptor antagonists
ZA200904479B (en) Nitroderivatives as angiotensin II receptor antagonists
HK1137353A1 (en) Urotensin ii receptor antagonists ii
IL202454A0 (en) Urotensin ii receptor antagonists
ZA200802339B (en) Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
ZA200903496B (en) Spiro-piperidine derivatives as via receptor antagonists
EP2250168A4 (en) ANTAGONISTS OF ANGIOTENSIN II RECEPTORS